Vertex Pharmaceuticals Inc
XBER:VX1
Vertex Pharmaceuticals Inc
XBER:VX1
Price:
411.7
EUR
-1.15%
Market Closed
Market Cap:
€43.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
Vertex Pharmaceuticals Inc
XBER:VX1
|
US |
|
Weyerhaeuser Co
NYSE:WY
|
US |
|
Showa Denko KK
OTC:SHWDF
|
JP |
|
Merdeka Copper Gold Tbk PT
F:B0C
|
ID |
|
L
|
Lenovo Group Ltd
OTC:LNVGF
|
CN |
|
Enact Holdings Inc
NASDAQ:ACT
|
US |
|
Ulisse Biomed Spa
MIL:UBM
|
IT |
|
Welltower Inc
NYSE:WELL
|
US |
|
China Overseas Land & Investment Ltd
HKEX:688
|
HK |
|
I
|
Indian Railway Finance Corp Ltd
BSE:543257
|
IN |
|
W
|
Williams Companies Inc
XHAM:WMB
|
US |
|
E
|
Encompass Health Corp
SWB:HSOA
|
US |
|
Stora Enso Oyj
LSE:0CXC
|
FI |
|
E
|
Exxon Mobil Corp
BMV:XOM
|
US |
|
Dixon Technologies (India) Ltd
NSE:DIXON
|
IN |
|
T
|
Trent Ltd
BSE:500251
|
IN |
Multiples-Based Value
The Multiples-Based Value for 
Vertex Pharmaceuticals Inc (VX1) under the Base Case is hidden
EUR.
Compared with the current market price of 411.7 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VX1 Multiples-Based Value
LOCKED
